Francesco Iorio
@francescoiorio.bsky.social
Research group leader @humantechnopole, cancer researcher, algorithm designer, dad, cook, failed singer, resting runner 😉
Pinned
🧬 Excited to announce the 2nd Euro Cancer DepMap Symposium bringing together leading minds in functional genomics, cancer vulnerabilities, AI, CRISPR and anti-cancer target discovery.📍Join us in Milan for cutting-edge science, open discussion & collaboration. #EuroDepMap #CancerResearch #CRISPR
Last chance to register. Hurry Up!
🧬 Excited to announce the 2nd Euro Cancer DepMap Symposium bringing together leading minds in functional genomics, cancer vulnerabilities, AI, CRISPR and anti-cancer target discovery.📍Join us in Milan for cutting-edge science, open discussion & collaboration. #EuroDepMap #CancerResearch #CRISPR
November 3, 2025 at 1:50 PM
Last chance to register. Hurry Up!
Reposted by Francesco Iorio
The Iorio Lab is at the 37th AICC International Meeting in Florence this week. With our Francesco Iorio presenting as an invited speaker, Nevenka Radic with a flash talk and Vanessa Spagnolo with a poster. Excited to share our latest results and connect with colleagues in the field.
October 29, 2025 at 1:30 PM
The Iorio Lab is at the 37th AICC International Meeting in Florence this week. With our Francesco Iorio presenting as an invited speaker, Nevenka Radic with a flash talk and Vanessa Spagnolo with a poster. Excited to share our latest results and connect with colleagues in the field.
Reposted by Francesco Iorio
Kudos to our Flavio Passante for winning with his team the REMEDi4ALL Hackathon in Barcellona! Researchers from 10 countries tackled real-world challenges in drug repurposing for rare neurodevelopmental disorders, spanning the whole pipeline from early target discovery to market access.
October 23, 2025 at 11:48 AM
Kudos to our Flavio Passante for winning with his team the REMEDi4ALL Hackathon in Barcellona! Researchers from 10 countries tackled real-world challenges in drug repurposing for rare neurodevelopmental disorders, spanning the whole pipeline from early target discovery to market access.
Congratulations Raffaele!
Our very own Raffaele Iannuzzi successfully defended his PhD Thesis last week. Raf has worked on benchmarking CRISPRdata analytical tool and predictive models leveraging bulk & single cell RNA-seq data. We will definitely miss him. We wish him all the best as new adventures await! Congrats Raf! 🎉
October 23, 2025 at 7:49 AM
Congratulations Raffaele!
Reposted by Francesco Iorio
Our very own Raffaele Iannuzzi successfully defended his PhD Thesis last week. Raf has worked on benchmarking CRISPRdata analytical tool and predictive models leveraging bulk & single cell RNA-seq data. We will definitely miss him. We wish him all the best as new adventures await! Congrats Raf! 🎉
October 22, 2025 at 7:23 AM
Our very own Raffaele Iannuzzi successfully defended his PhD Thesis last week. Raf has worked on benchmarking CRISPRdata analytical tool and predictive models leveraging bulk & single cell RNA-seq data. We will definitely miss him. We wish him all the best as new adventures await! Congrats Raf! 🎉
Reposted by Francesco Iorio
!!! Less than 2 weeks left to register !!! Join us in Milan for the 2nd European Cancer Dependency Map Symposium, taking place on 20 November 2025 at Human Technopole
Cancer functional genomics; CRISPR-based screening;
AIdriven targetDiscovery and drug development
humantechnopole.it/en/trainings...
Cancer functional genomics; CRISPR-based screening;
AIdriven targetDiscovery and drug development
humantechnopole.it/en/trainings...
October 21, 2025 at 10:08 AM
!!! Less than 2 weeks left to register !!! Join us in Milan for the 2nd European Cancer Dependency Map Symposium, taking place on 20 November 2025 at Human Technopole
Cancer functional genomics; CRISPR-based screening;
AIdriven targetDiscovery and drug development
humantechnopole.it/en/trainings...
Cancer functional genomics; CRISPR-based screening;
AIdriven targetDiscovery and drug development
humantechnopole.it/en/trainings...
Reposted by Francesco Iorio
CLOSING: Postdoc in @francescoiorio.bsky.social's lab at @humantechnopole.bsky.social
Apply through LinkedIn by 5 October: www.linkedin.com/jobs/view/43...
#scienceJobs #AcademicSky #postdocJobs
Apply through LinkedIn by 5 October: www.linkedin.com/jobs/view/43...
#scienceJobs #AcademicSky #postdocJobs
October 3, 2025 at 9:54 AM
CLOSING: Postdoc in @francescoiorio.bsky.social's lab at @humantechnopole.bsky.social
Apply through LinkedIn by 5 October: www.linkedin.com/jobs/view/43...
#scienceJobs #AcademicSky #postdocJobs
Apply through LinkedIn by 5 October: www.linkedin.com/jobs/view/43...
#scienceJobs #AcademicSky #postdocJobs
Reposted by Francesco Iorio
Join us for this exciting meeting!
📢 The 2nd European Cancer Dependency Map Symposium is coming!
🗓️ 20 Nov 2025
📍 Human Technopole, Milan
Join us for a one-day dive into:
🔹 Cancer genomics
🔹 CRISPR screening
🔹 AI-driven target discovery
With the patronage of AIRC
🔗 humantechnopole.it/en/trainings...
🗓️ 20 Nov 2025
📍 Human Technopole, Milan
Join us for a one-day dive into:
🔹 Cancer genomics
🔹 CRISPR screening
🔹 AI-driven target discovery
With the patronage of AIRC
🔗 humantechnopole.it/en/trainings...
2nd European Cancer Dependency Map Symposium - Human Technopole
The 2nd European Cancer Dependency Map Symposium is a scientific event open to the national and international scientific community working in computational genomics, pharmacogenomics, and therapeutic ...
humantechnopole.it
September 17, 2025 at 12:36 PM
Join us for this exciting meeting!
📢 The 2nd European Cancer Dependency Map Symposium is coming!
🗓️ 20 Nov 2025
📍 Human Technopole, Milan
Join us for a one-day dive into:
🔹 Cancer genomics
🔹 CRISPR screening
🔹 AI-driven target discovery
With the patronage of AIRC
🔗 humantechnopole.it/en/trainings...
🗓️ 20 Nov 2025
📍 Human Technopole, Milan
Join us for a one-day dive into:
🔹 Cancer genomics
🔹 CRISPR screening
🔹 AI-driven target discovery
With the patronage of AIRC
🔗 humantechnopole.it/en/trainings...
2nd European Cancer Dependency Map Symposium - Human Technopole
The 2nd European Cancer Dependency Map Symposium is a scientific event open to the national and international scientific community working in computational genomics, pharmacogenomics, and therapeutic ...
humantechnopole.it
September 17, 2025 at 10:05 AM
📢 The 2nd European Cancer Dependency Map Symposium is coming!
🗓️ 20 Nov 2025
📍 Human Technopole, Milan
Join us for a one-day dive into:
🔹 Cancer genomics
🔹 CRISPR screening
🔹 AI-driven target discovery
With the patronage of AIRC
🔗 humantechnopole.it/en/trainings...
🗓️ 20 Nov 2025
📍 Human Technopole, Milan
Join us for a one-day dive into:
🔹 Cancer genomics
🔹 CRISPR screening
🔹 AI-driven target discovery
With the patronage of AIRC
🔗 humantechnopole.it/en/trainings...
Reposted by Francesco Iorio
Francesco will be speaking at the High-Content CRISPR Screening conference, taking place March 18–19, 2026 in Vienna 🇦🇹 alongside leading experts in CRISPR screening, functional genomics, and drug discovery
www.linkedin.com/posts/myllia...
www.linkedin.com/posts/myllia...
The registration and abstract submission for the "High-Content CRISPR Screening" conference on March 18–19, 2026, in Vienna, Austria is now open!
Secure your spot via the conference website...
The registration and abstract submission for the "High-Content CRISPR Screening" conference on March 18–19, 2026, in Vienna, Austria is now open!
Secure your spot via the conference website: https://...
www.linkedin.com
September 16, 2025 at 12:04 PM
Francesco will be speaking at the High-Content CRISPR Screening conference, taking place March 18–19, 2026 in Vienna 🇦🇹 alongside leading experts in CRISPR screening, functional genomics, and drug discovery
www.linkedin.com/posts/myllia...
www.linkedin.com/posts/myllia...
10 September 2025
September 11, 2025 at 8:22 PM
10 September 2025
Join Us! @ioriolab.bsky.social
🚨 We’re hiring! 🚨 looking for a computational postdoc to lead an exciting project at the intersection of AI, CRISPR, multi-omics, and cancer genomics.
Join us to design the next generation of genetic interaction screens and uncover new synthetic lethalities
www.linkedin.com/jobs/view/42...
Join us to design the next generation of genetic interaction screens and uncover new synthetic lethalities
www.linkedin.com/jobs/view/42...
Human Technopole hiring Postdoc in Cancer Synthetic Lethality Prediction and AI-Driven Target Discovery in Milan, Lombardy, Italy | LinkedIn
Posted 2:37:53 PM. APPLICATION CLOSING DATE: October 12, 2025Human Technopole (HT) is an interdisciplinary life…See this and similar jobs on LinkedIn.
www.linkedin.com
September 11, 2025 at 4:31 PM
Join Us! @ioriolab.bsky.social
Reposted by Francesco Iorio
Today we bid farewell to our postDoc @aurorasavino.bsky.social, who is moving to an independent position at the University of Torino. Her talent dedication and collaborative spirit have left a lasting mark on our team and projects🎉
Wishing you all the best for this exciting next chapter, Aurora!
🥳🍾
Wishing you all the best for this exciting next chapter, Aurora!
🥳🍾
September 11, 2025 at 12:33 PM
Today we bid farewell to our postDoc @aurorasavino.bsky.social, who is moving to an independent position at the University of Torino. Her talent dedication and collaborative spirit have left a lasting mark on our team and projects🎉
Wishing you all the best for this exciting next chapter, Aurora!
🥳🍾
Wishing you all the best for this exciting next chapter, Aurora!
🥳🍾
Excited to share that I’ve joined the Scientific Advisory Board of #DrugReKindle, a startup harnessing AI and computational biology to advance drug repurposing across human diseases.
Grateful to the team for the opportunity. Looking forward to the journey ahead.
www.linkedin.com/posts/drugre...
Grateful to the team for the opportunity. Looking forward to the journey ahead.
www.linkedin.com/posts/drugre...
#drugrekindle #drugrepurposing #aiinbiotech #smarterdrugdiscovery #healthinnovation #precisionmedicine #translationalscience #repurposetoadvance | DrugReKindle
🔄 Drug Repurposing: A Smarter Way to Unlock Therapeutic Value
The current model of drug development is expensive, risky, and painfully slow. Bringing a new drug to market takes 10–15 years and over $2...
www.linkedin.com
August 30, 2025 at 3:28 PM
Excited to share that I’ve joined the Scientific Advisory Board of #DrugReKindle, a startup harnessing AI and computational biology to advance drug repurposing across human diseases.
Grateful to the team for the opportunity. Looking forward to the journey ahead.
www.linkedin.com/posts/drugre...
Grateful to the team for the opportunity. Looking forward to the journey ahead.
www.linkedin.com/posts/drugre...
Just back from the GRC on Synthetic Lethality in Oncology: great science, deep discussion, great venue and flawless organisation. Thanks to @mgarnett.bsky.social, Benjamin Schwartz & @vazquezf.bsky.social for leading a fantastic meeting at the frontier of cancer research #SyntheticLethality #GRC
July 25, 2025 at 3:36 PM
Just back from the GRC on Synthetic Lethality in Oncology: great science, deep discussion, great venue and flawless organisation. Thanks to @mgarnett.bsky.social, Benjamin Schwartz & @vazquezf.bsky.social for leading a fantastic meeting at the frontier of cancer research #SyntheticLethality #GRC
Reposted by Francesco Iorio
Enjoying the Gordon Conference on Synthetic Lethality in Oncology with @francescoiorio.bsky.social and @maxbillmann.bsky.social 😊 #bioinformatics #gordonConference #syntheticLethality
July 24, 2025 at 5:58 PM
Enjoying the Gordon Conference on Synthetic Lethality in Oncology with @francescoiorio.bsky.social and @maxbillmann.bsky.social 😊 #bioinformatics #gordonConference #syntheticLethality
happy and honoured to have had a chance to deliver a lecture @bocconi.bsky.social University on AIapplications in life sciences and to share exciting projects we are developing at @humantechnopole.bsky.social-
A great opportunity to engage with a community that values innovation and forwardThinking
A great opportunity to engage with a community that values innovation and forwardThinking
July 18, 2025 at 6:16 PM
happy and honoured to have had a chance to deliver a lecture @bocconi.bsky.social University on AIapplications in life sciences and to share exciting projects we are developing at @humantechnopole.bsky.social-
A great opportunity to engage with a community that values innovation and forwardThinking
A great opportunity to engage with a community that values innovation and forwardThinking
great work from @davidjadams.bsky.social out now in @natgenet.nature.com (with a computational contribution from the @ioriolab.bsky.social @humantechnopole.bsky.social led by A.Vinceti)
New work out in @natgenet.nature.com from @davidjadams.bsky.social Lab @sangerinstitute.bsky.social (with a contribution from us led by A.Vinceti): CDS2 is a cancer dependency in uveal melanomas with low CDS1 expression: a synthetic lethal axis with broad potential
🔗 www.nature.com/articles/s41...
🔗 www.nature.com/articles/s41...
The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor types - Nature Genetics
This study employs a functional genomic approach to identify a synthetic lethal interaction between CDS1 and CDS2 in uveal melanoma and other cancers, which may represent a potential therapeutic targe...
www.nature.com
July 6, 2025 at 3:17 PM
great work from @davidjadams.bsky.social out now in @natgenet.nature.com (with a computational contribution from the @ioriolab.bsky.social @humantechnopole.bsky.social led by A.Vinceti)
Proud to announce that the 2nd European Cancer DepMap Symposium has the patronage of AIRC: the Italian Association for Cancer Research. Honoured by their support as we bring together leading scientists on cancer-dependencies functional-genomics CRISPR
🔗 humantechnopole.it/en/trainings...
#EuroDepMap
🔗 humantechnopole.it/en/trainings...
#EuroDepMap
June 19, 2025 at 11:40 AM
Proud to announce that the 2nd European Cancer DepMap Symposium has the patronage of AIRC: the Italian Association for Cancer Research. Honoured by their support as we bring together leading scientists on cancer-dependencies functional-genomics CRISPR
🔗 humantechnopole.it/en/trainings...
#EuroDepMap
🔗 humantechnopole.it/en/trainings...
#EuroDepMap
Reposted by Francesco Iorio
we are at #EACR2025 with two posters - the second one is presented by Ludovica Proietti and Gianluca vozza and focuses on our ERC funded DEPshock project
@humantechnopole.bsky.social
@humantechnopole.bsky.social
June 18, 2025 at 11:57 AM
we are at #EACR2025 with two posters - the second one is presented by Ludovica Proietti and Gianluca vozza and focuses on our ERC funded DEPshock project
@humantechnopole.bsky.social
@humantechnopole.bsky.social
Reposted by Francesco Iorio
we are at #EACR2025 with two posters, one presented by our Ottavio Croci on our collaborative work around a CRISPR based prioritisation of lncRNA vulnerabilities in multiple myeloma @humantechnopole.bsky.social
June 18, 2025 at 7:32 AM
we are at #EACR2025 with two posters, one presented by our Ottavio Croci on our collaborative work around a CRISPR based prioritisation of lncRNA vulnerabilities in multiple myeloma @humantechnopole.bsky.social
Cingratulations @diegodibi.bsky.social !! Well deserved 💪
I got an ERC Advanced Grant :))))) www.eurekalert.org/news-release...
ERC awards €2.5 million to TIGEM scientist for project on programmable genetic circuits
Diego Di Bernardo of the Telethon Institute of Genetics and Medicine (TIGEM) has received a €2.5 million ERC Advanced Grant for DIMERCIRCUITS, a project that combines synthetic biology, artificia...
www.eurekalert.org
June 17, 2025 at 8:07 PM
Cingratulations @diegodibi.bsky.social !! Well deserved 💪
Following the success of the first European Cancer Dependency Map Symposium in 2023, we are excited to announce the 2nd edition, to be held at Human Technopole on the 20th November 2025. Registration and Poster submission now open!
humantechnopole.it/en/trainings...
youtu.be/x2erCuovGvc
#EuroDepMap
humantechnopole.it/en/trainings...
youtu.be/x2erCuovGvc
#EuroDepMap
1st European Cancer Dependency Map Symposium
YouTube video by Human Technopole
youtu.be
June 11, 2025 at 4:06 PM
Following the success of the first European Cancer Dependency Map Symposium in 2023, we are excited to announce the 2nd edition, to be held at Human Technopole on the 20th November 2025. Registration and Poster submission now open!
humantechnopole.it/en/trainings...
youtu.be/x2erCuovGvc
#EuroDepMap
humantechnopole.it/en/trainings...
youtu.be/x2erCuovGvc
#EuroDepMap
🧬 Excited to announce the 2nd Euro Cancer DepMap Symposium bringing together leading minds in functional genomics, cancer vulnerabilities, AI, CRISPR and anti-cancer target discovery.📍Join us in Milan for cutting-edge science, open discussion & collaboration. #EuroDepMap #CancerResearch #CRISPR
June 11, 2025 at 3:00 PM
🧬 Excited to announce the 2nd Euro Cancer DepMap Symposium bringing together leading minds in functional genomics, cancer vulnerabilities, AI, CRISPR and anti-cancer target discovery.📍Join us in Milan for cutting-edge science, open discussion & collaboration. #EuroDepMap #CancerResearch #CRISPR
Reposted by Francesco Iorio
www.sciencedirect.com/science/arti... Just found out that our work on computational drug repositioning (mantra.tigem.it) among the 20 most cited articles worldwide in Scopus that are part of the collection. @francescoiorio.bsky.social
A bibliometric review on in silico drug repurposing: Performance analysis, science mapping and text mining (2000–2023)
Drug repositioning is a technique to investigate whether a drug already approved for one disease will function for another disease not included in the…
www.sciencedirect.com
April 28, 2025 at 3:15 PM
www.sciencedirect.com/science/arti... Just found out that our work on computational drug repositioning (mantra.tigem.it) among the 20 most cited articles worldwide in Scopus that are part of the collection. @francescoiorio.bsky.social